Dr. Jacob Orme
Claim this profileMayo Clinic in Rochester
Studies Prostate Cancer
Studies Melanoma
6 reported clinical trials
17 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
SPOP positive
2Melanoma
PD-L1 positive
Affiliated Hospitals
Clinical Trials Jacob Orme is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Radiation and Hormone Therapy
for Prostate Cancer
This phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT) in treating patients with hormone sensitive prostate cancer that has spread from where it first started to other places in the body (metastatic), and that has come back after a period of improvement (recurrent). SBRT is a type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except the brain). The total dose of radiation is divided into smaller doses given over several days. This type of radiation therapy helps spare normal tissue. Androgen can cause the growth of prostate cells. ADT lowers the amount of androgen made by the body. This may help stop the growth of tumor cells that need androgen to grow. Androgen receptor pathway inhibitors work by blocking the effects of androgen to stop the growth and spread of tumor cells. Giving SBRT alone with watchful waiting may be as effective in treating prostate cancer as giving SBRT together with ARPI and ADT.
Recruiting1 award Phase 24 criteria
More about Jacob Orme
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jacob Orme has experience with
- Enzalutamide
- Hyaluronidase-zzxf
- Pertuzumab
- Trastuzumab
- M1774
- Abiraterone
Breakdown of trials Jacob Orme has run
Prostate Cancer
Melanoma
Extrapulmonary Neuroendocrine Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacob Orme specialize in?
Jacob Orme focuses on Prostate Cancer and Melanoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are SPOP positive.
Is Jacob Orme currently recruiting for clinical trials?
Yes, Jacob Orme is currently recruiting for 2 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Jacob Orme has studied deeply?
Yes, Jacob Orme has studied treatments such as Enzalutamide, Hyaluronidase-zzxf, Pertuzumab.
What is the best way to schedule an appointment with Jacob Orme?
Apply for one of the trials that Jacob Orme is conducting.
What is the office address of Jacob Orme?
The office of Jacob Orme is located at: Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic in Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.